Table 2.xls (5.5 kB)

EGFR mutation testing rates by year in 12,148 patients who underwent EGFR testing.

Name: EGFR mutation testing rates by year in 12,148 patients who underwent EGFR testing.
Published: 2019-01-04T18:43:12+00:00
Keywords: tyrosine kinase inhibitors, first-line, exon 21 L 858R mutation, Flatiron Electronic Health Record-derived database, USA Background Randomized phase III trials, EGFR Mut, epidermal growth factor receptor, IIIB, retrospective cohort study, NSCLC, EGFR tyrosine kinase inhibitor, IV, exon 19 deletion

dataset

posted on 04.01.2019, 18:43 by Yulin Li, Anita Appius, Thirupathi Pattipaka, Andrea Feyereislova, Adrian Cassidy, Apar Kishor Ganti

EGFR mutation testing rates by year in 12,148 patients who underwent EGFR testing.

EGFR mutation testing rates by year in 12,148 patients who underwent EGFR testing.

History

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports